APTA Colorado AIM/Anthem Survey

Question Title

* 1. Did your facility receive written notification from Anthem on the change to AIM in advance of the program implementation?

Yes

Question Title

* 2. Have you received notice that Anthem-AIM will be taking over authorization for Commercial Products requiring all new authorizations on July 1st, 2019?

Yes

Question Title

* 3. Did your office participate in a training session before the go live date?

Yes

Question Title

* 4. Are you currently experiencing problems using the web portal to complete an authorization?

Yes

Question Title

* 5. On average, how long are the current phone wait times?

Less than 5 minutes

5 - 30 minutes

30 minutes - 1 hour

1 hour - 1.5 hours

More than 1.5 hours

Question Title

* 6. Is your support staff able to enter the authorization data without PT assistance? (I.e. could the requested information be completed without the skills of the PT to interpret and enter the appropriate data?)

Yes

Question Title

* 7. How long does it take on average for administrative and clinical staff combined to complete one initial or follow up authorization?

Less than 5 minutes

5 - 30 minutes

30 minutes - 1 hour

More than 1 hour

Question Title

* 8. How many visits are typically authorized in the INITIAL authorization period?

Question Title

* 9. How frequently were the requested visits granted on the INITIAL authorization?

25%

50%

75%

100%

Question Title

* 10. Is the date range on the initial authorization reasonable?

Yes

Question Title

* 11. How many visits are typically authorized in the SECOND authorization period?

Question Title

* 12. How frequently were the requested visits granted on the SECOND authorization?

25%

50%

75%

100%

Question Title

* 13. Is the date range on the second authorization reasonable?

Yes

Question Title

* 14. On average, how long does it take to get a response to an authorization request?

Less than 5 minutes

1-16 hours

1 day

2 days

3 days

More than 3 days

Question Title

* 15. Are there differences in the number of authorized visits between patients with orthopedic conditions and those patients with nonorthopedic or complex conditions?

Yes

Question Title

* 16. Are appropriate clinical data and outcome measures considered during the authorization approval process?

Yes

Question Title

* 17. Is the frequency of requested functional tool measures consistent with best practice?

Yes

Question Title

* 18. What is your perceived assessment of the AIM program’s adverse impact on patient outcomes?

No impact

Minimal impact

Moderate impact

Severe impact

Question Title

* 19. In what areas are your patients adversely affected? Check all that apply:

Scheduling

Intensity of services needed

Duration of services needed

Other (please specify)

Question Title

* 20. What mode of authorization transmisson do you use most often?

Fax

Phone

Web portal

Question Title

* 21. Given a choice, what is your preferred mode of authorization transmission?

Fax

Phone

Web portal

Question Title

* 22. Are you experiencing claims payment issues related to the AIM program?

Yes

Question Title

* 23. Have you contacted AIM or Anthem for additional assistance?

Yes

APTA Colorado AIM/Anthem Survey

Question Title

* 1. Did your facility receive written notification from Anthem on the change to AIM in advance of the program implementation?

Question Title

* 2. Have you received notice that Anthem-AIM will be taking over authorization for Commercial Products requiring all new authorizations on July 1st, 2019?

Question Title

* 3. Did your office participate in a training session before the go live date?

Question Title

* 4. Are you currently experiencing problems using the web portal to complete an authorization?

Question Title

* 5. On average, how long are the current phone wait times?

Question Title

* 6. Is your support staff able to enter the authorization data without PT assistance? (I.e. could the requested information be completed without the skills of the PT to interpret and enter the appropriate data?)

Question Title

* 7. How long does it take on average for administrative and clinical staff combined to complete one initial or follow up authorization?

Question Title

* 8. How many visits are typically authorized in the INITIAL authorization period?

Question Title

* 9. How frequently were the requested visits granted on the INITIAL authorization?

Question Title

* 10. Is the date range on the initial authorization reasonable?

Question Title

* 11. How many visits are typically authorized in the SECOND authorization period?

Question Title

* 12. How frequently were the requested visits granted on the SECOND authorization?

Question Title

* 13. Is the date range on the second authorization reasonable?

Question Title

* 14. On average, how long does it take to get a response to an authorization request?

Question Title

* 15. Are there differences in the number of authorized visits between patients with orthopedic conditions and those patients with nonorthopedic or complex conditions?

Question Title

* 16. Are appropriate clinical data and outcome measures considered during the authorization approval process?

Question Title

* 17. Is the frequency of requested functional tool measures consistent with best practice?

Question Title

* 18. What is your perceived assessment of the AIM program’s adverse impact on patient outcomes?

Question Title

* 19. In what areas are your patients adversely affected? Check all that apply:

Question Title

* 20. What mode of authorization transmisson do you use most often?

Question Title

* 21. Given a choice, what is your preferred mode of authorization transmission?

Question Title

* 22. Are you experiencing claims payment issues related to the AIM program?

Question Title

* 23. Have you contacted AIM or Anthem for additional assistance?

Question Title

* 24. Did AIM/Anthem resolve your issue related to your contact?

Question Title

* 25. Additional Comments